Drug Information Association Logo
« Back to Listing

Dare to Be Different: Comparing Biosensor Data to Patient-Reported Outcomes Data - Learnings from Asthma

Track:
Medical Devices, In Vitro Diagnostics, and Combination Products

Day & Time:
June 17, 1:30PM - 2:30PM (Pacific Standard Time)

Session Number:
269

Room Number:
11A

Level:
Intermediate

Type:
Session

Title:
Dare to Be Different: Comparing Biosensor Data to Patient-Reported Outcomes Data - Learnings from Asthma

Chair(s):
Alison Greene
Genentech, A Member of the Roche Group, United States

Description:
A study of asthma patients compared data collected by wearable-device and “usual” self-reported diary format. Session topics include: Lessons learned, implications for clinical trial design, and wider landscape of biosensors in clinical studies.

Learning Objective(s):
Discuss the context and considerations for including biosensors in drug development trials; Manage the technical issues for successful implementation in a study; Describe the current landscape and status of biosensor use in clinical studies.

Presentation(s) & Speaker(s):
Rethinking Outcomes Assessments: Where Do Biosensors Fit in Drug Development?
Alison Greene
Genentech, A Member of the Roche Group, United States

Implementing New Technology in Clinical Trials: An Interesting Adventure
John Reites
Senior Director, Offer and Product Development
Quintiles Inc., United States